nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCG2—hematologic cancer	0.163	0.706	CbGaD
Venlafaxine—ABCB1—hematologic cancer	0.0676	0.294	CbGaD
Venlafaxine—ABCG2—Clofarabine—hematologic cancer	0.027	0.0569	CbGbCtD
Venlafaxine—ABCG2—Daunorubicin—hematologic cancer	0.0159	0.0334	CbGbCtD
Venlafaxine—CYP2B6—Thiotepa—hematologic cancer	0.0158	0.0332	CbGbCtD
Venlafaxine—ABCG2—Teniposide—hematologic cancer	0.0138	0.029	CbGbCtD
Venlafaxine—ABCG2—Cladribine—hematologic cancer	0.0132	0.0278	CbGbCtD
Venlafaxine—ABCG2—Imatinib—hematologic cancer	0.0121	0.0256	CbGbCtD
Venlafaxine—ABCG2—Nilotinib—hematologic cancer	0.011	0.0232	CbGbCtD
Venlafaxine—CYP2C9—Bexarotene—hematologic cancer	0.01	0.0212	CbGbCtD
Venlafaxine—ABCG2—Dasatinib—hematologic cancer	0.00975	0.0205	CbGbCtD
Venlafaxine—ABCB1—Lenalidomide—hematologic cancer	0.00975	0.0205	CbGbCtD
Venlafaxine—ABCG2—Mitoxantrone—hematologic cancer	0.00963	0.0203	CbGbCtD
Venlafaxine—CYP2B6—Ifosfamide—hematologic cancer	0.00894	0.0188	CbGbCtD
Venlafaxine—CYP2D6—Lomustine—hematologic cancer	0.00854	0.018	CbGbCtD
Venlafaxine—CYP2C9—Idarubicin—hematologic cancer	0.00832	0.0175	CbGbCtD
Venlafaxine—CYP2B6—Nilotinib—hematologic cancer	0.00776	0.0163	CbGbCtD
Venlafaxine—CYP2D6—Idarubicin—hematologic cancer	0.00761	0.016	CbGbCtD
Venlafaxine—ABCG2—Irinotecan—hematologic cancer	0.00758	0.016	CbGbCtD
Venlafaxine—CYP2C19—Bortezomib—hematologic cancer	0.00741	0.0156	CbGbCtD
Venlafaxine—ABCG2—Vincristine—hematologic cancer	0.00663	0.014	CbGbCtD
Venlafaxine—CYP2D6—Hydroxyurea—hematologic cancer	0.00647	0.0136	CbGbCtD
Venlafaxine—CYP2C19—Thalidomide—hematologic cancer	0.00645	0.0136	CbGbCtD
Venlafaxine—ABCG2—Cisplatin—hematologic cancer	0.00618	0.013	CbGbCtD
Venlafaxine—CYP2C9—Bortezomib—hematologic cancer	0.00616	0.013	CbGbCtD
Venlafaxine—CYP2C19—Teniposide—hematologic cancer	0.00615	0.013	CbGbCtD
Venlafaxine—ABCG2—Etoposide—hematologic cancer	0.00607	0.0128	CbGbCtD
Venlafaxine—CYP3A4—Bexarotene—hematologic cancer	0.00584	0.0123	CbGbCtD
Venlafaxine—ABCB1—Daunorubicin—hematologic cancer	0.00572	0.012	CbGbCtD
Venlafaxine—CYP2C19—Ifosfamide—hematologic cancer	0.00568	0.012	CbGbCtD
Venlafaxine—CYP2D6—Bortezomib—hematologic cancer	0.00563	0.0119	CbGbCtD
Venlafaxine—ABCB1—Alitretinoin—hematologic cancer	0.0056	0.0118	CbGbCtD
Venlafaxine—CYP3A4—Busulfan—hematologic cancer	0.00543	0.0114	CbGbCtD
Venlafaxine—CYP3A4—Lomustine—hematologic cancer	0.00543	0.0114	CbGbCtD
Venlafaxine—CYP2C19—Imatinib—hematologic cancer	0.00543	0.0114	CbGbCtD
Venlafaxine—CYP2C9—Thalidomide—hematologic cancer	0.00536	0.0113	CbGbCtD
Venlafaxine—CYP2B6—Irinotecan—hematologic cancer	0.00533	0.0112	CbGbCtD
Venlafaxine—CYP2C9—Teniposide—hematologic cancer	0.00512	0.0108	CbGbCtD
Venlafaxine—ABCG2—Dexamethasone—hematologic cancer	0.00499	0.0105	CbGbCtD
Venlafaxine—CYP3A4—Thiotepa—hematologic cancer	0.00484	0.0102	CbGbCtD
Venlafaxine—CYP2C9—Ifosfamide—hematologic cancer	0.00472	0.00994	CbGbCtD
Venlafaxine—CYP2C9—Imatinib—hematologic cancer	0.00451	0.0095	CbGbCtD
Venlafaxine—ABCB1—Imatinib—hematologic cancer	0.00438	0.00922	CbGbCtD
Venlafaxine—CYP2B6—Cisplatin—hematologic cancer	0.00435	0.00916	CbGbCtD
Venlafaxine—ABCG2—Doxorubicin—hematologic cancer	0.00414	0.00872	CbGbCtD
Venlafaxine—CYP2D6—Imatinib—hematologic cancer	0.00413	0.00869	CbGbCtD
Venlafaxine—CYP2C9—Nilotinib—hematologic cancer	0.0041	0.00863	CbGbCtD
Venlafaxine—ABCG2—Methotrexate—hematologic cancer	0.00401	0.00845	CbGbCtD
Venlafaxine—ABCB1—Nilotinib—hematologic cancer	0.00398	0.00838	CbGbCtD
Venlafaxine—ABCB1—Vinorelbine—hematologic cancer	0.00395	0.00831	CbGbCtD
Venlafaxine—CYP3A4—Methoxsalen—hematologic cancer	0.00376	0.00793	CbGbCtD
Venlafaxine—CYP2D6—Nilotinib—hematologic cancer	0.00375	0.00789	CbGbCtD
Venlafaxine—CYP2D6—Vinorelbine—hematologic cancer	0.00372	0.00783	CbGbCtD
Venlafaxine—CYP3A4—Bortezomib—hematologic cancer	0.00358	0.00754	CbGbCtD
Venlafaxine—CYP2C19—Prednisone—hematologic cancer	0.00357	0.00753	CbGbCtD
Venlafaxine—ABCB1—Dasatinib—hematologic cancer	0.00352	0.0074	CbGbCtD
Venlafaxine—CYP2B6—Dexamethasone—hematologic cancer	0.00351	0.0074	CbGbCtD
Venlafaxine—ABCB1—Mitoxantrone—hematologic cancer	0.00347	0.00731	CbGbCtD
Venlafaxine—CYP3A4—Daunorubicin—hematologic cancer	0.00342	0.00721	CbGbCtD
Venlafaxine—ABCB1—Betamethasone—hematologic cancer	0.0031	0.00652	CbGbCtD
Venlafaxine—ABCB1—Gemcitabine—hematologic cancer	0.00307	0.00646	CbGbCtD
Venlafaxine—ABCB1—Prednisolone—hematologic cancer	0.00305	0.00643	CbGbCtD
Venlafaxine—CYP3A4—Cytarabine—hematologic cancer	0.00302	0.00636	CbGbCtD
Venlafaxine—CYP3A4—Teniposide—hematologic cancer	0.00298	0.00627	CbGbCtD
Venlafaxine—CYP2B6—Doxorubicin—hematologic cancer	0.00291	0.00614	CbGbCtD
Venlafaxine—ABCB1—Prednisone—hematologic cancer	0.00288	0.00607	CbGbCtD
Venlafaxine—CYP3A4—Ifosfamide—hematologic cancer	0.00275	0.00578	CbGbCtD
Venlafaxine—ABCB1—Irinotecan—hematologic cancer	0.00273	0.00576	CbGbCtD
Venlafaxine—CYP3A4—Imatinib—hematologic cancer	0.00262	0.00552	CbGbCtD
Venlafaxine—CYP3A4—Ruxolitinib—hematologic cancer	0.00247	0.0052	CbGbCtD
Venlafaxine—ABCB1—Vinblastine—hematologic cancer	0.00243	0.00512	CbGbCtD
Venlafaxine—ABCB1—Vincristine—hematologic cancer	0.00239	0.00503	CbGbCtD
Venlafaxine—CYP3A4—Nilotinib—hematologic cancer	0.00238	0.00502	CbGbCtD
Venlafaxine—CYP3A4—Vinorelbine—hematologic cancer	0.00236	0.00498	CbGbCtD
Venlafaxine—CYP2C9—Cisplatin—hematologic cancer	0.0023	0.00484	CbGbCtD
Venlafaxine—CYP2D6—Vinblastine—hematologic cancer	0.00229	0.00482	CbGbCtD
Venlafaxine—CYP2C19—Dexamethasone—hematologic cancer	0.00223	0.0047	CbGbCtD
Venlafaxine—ABCB1—Cisplatin—hematologic cancer	0.00223	0.00469	CbGbCtD
Venlafaxine—ABCB1—Etoposide—hematologic cancer	0.00219	0.00461	CbGbCtD
Venlafaxine—NPY1R—hematopoietic system—hematologic cancer	0.00218	0.0959	CbGeAlD
Venlafaxine—CYP3A4—Triamcinolone—hematologic cancer	0.00216	0.00455	CbGbCtD
Venlafaxine—CYP3A4—Dasatinib—hematologic cancer	0.00211	0.00444	CbGbCtD
Venlafaxine—CYP3A4—Mitoxantrone—hematologic cancer	0.00208	0.00438	CbGbCtD
Venlafaxine—CYP2C9—Dexamethasone—hematologic cancer	0.00186	0.00391	CbGbCtD
Venlafaxine—CYP3A4—Betamethasone—hematologic cancer	0.00185	0.00391	CbGbCtD
Venlafaxine—CYP3A4—Prednisolone—hematologic cancer	0.00183	0.00385	CbGbCtD
Venlafaxine—ABCB1—Dexamethasone—hematologic cancer	0.0018	0.00379	CbGbCtD
Venlafaxine—CYP3A4—Prednisone—hematologic cancer	0.00173	0.00364	CbGbCtD
Venlafaxine—CYP2D6—Dexamethasone—hematologic cancer	0.0017	0.00357	CbGbCtD
Venlafaxine—NPY1R—gonad—hematologic cancer	0.00165	0.0729	CbGeAlD
Venlafaxine—CYP3A4—Irinotecan—hematologic cancer	0.00164	0.00345	CbGbCtD
Venlafaxine—ABCB1—Doxorubicin—hematologic cancer	0.00149	0.00315	CbGbCtD
Venlafaxine—CYP3A4—Vinblastine—hematologic cancer	0.00146	0.00307	CbGbCtD
Venlafaxine—ABCB1—Methotrexate—hematologic cancer	0.00145	0.00305	CbGbCtD
Venlafaxine—NPY1R—blood—hematologic cancer	0.00144	0.0636	CbGeAlD
Venlafaxine—CYP3A4—Vincristine—hematologic cancer	0.00143	0.00302	CbGbCtD
Venlafaxine—CYP2D6—Doxorubicin—hematologic cancer	0.00141	0.00296	CbGbCtD
Venlafaxine—CYP3A4—Etoposide—hematologic cancer	0.00131	0.00276	CbGbCtD
Venlafaxine—NPY1R—lung—hematologic cancer	0.00126	0.0557	CbGeAlD
Venlafaxine—NPY1R—testis—hematologic cancer	0.00119	0.0526	CbGeAlD
Venlafaxine—CYP3A4—Dexamethasone—hematologic cancer	0.00108	0.00227	CbGbCtD
Venlafaxine—SLC6A3—hematopoietic system—hematologic cancer	0.000916	0.0404	CbGeAlD
Venlafaxine—CYP3A4—Doxorubicin—hematologic cancer	0.000895	0.00188	CbGbCtD
Venlafaxine—NPY1R—lymph node—hematologic cancer	0.000865	0.0381	CbGeAlD
Venlafaxine—SLC6A4—hematopoietic system—hematologic cancer	0.000839	0.037	CbGeAlD
Venlafaxine—CYP2C19—hematopoietic system—hematologic cancer	0.000695	0.0306	CbGeAlD
Venlafaxine—SLC6A2—gonad—hematologic cancer	0.000562	0.0248	CbGeAlD
Venlafaxine—SLC6A4—blood—hematologic cancer	0.000556	0.0245	CbGeAlD
Venlafaxine—CYP2B6—hematopoietic system—hematologic cancer	0.000544	0.024	CbGeAlD
Venlafaxine—CYP2C9—hematopoietic system—hematologic cancer	0.000539	0.0238	CbGeAlD
Venlafaxine—SLC6A3—lung—hematologic cancer	0.000532	0.0234	CbGeAlD
Venlafaxine—SLC6A3—testis—hematologic cancer	0.000502	0.0221	CbGeAlD
Venlafaxine—SLC6A4—lung—hematologic cancer	0.000487	0.0215	CbGeAlD
Venlafaxine—CYP2C19—blood—hematologic cancer	0.000461	0.0203	CbGeAlD
Venlafaxine—SLC6A2—lung—hematologic cancer	0.000429	0.0189	CbGeAlD
Venlafaxine—CYP2B6—gonad—hematologic cancer	0.000414	0.0182	CbGeAlD
Venlafaxine—CYP3A4—hematopoietic system—hematologic cancer	0.000411	0.0181	CbGeAlD
Venlafaxine—SLC6A2—testis—hematologic cancer	0.000405	0.0178	CbGeAlD
Venlafaxine—CYP2D6—hematopoietic system—hematologic cancer	0.000405	0.0178	CbGeAlD
Venlafaxine—ABCG2—blood—hematologic cancer	0.000391	0.0172	CbGeAlD
Venlafaxine—ABCG2—bone marrow—hematologic cancer	0.000378	0.0167	CbGeAlD
Venlafaxine—CYP2B6—blood—hematologic cancer	0.000361	0.0159	CbGeAlD
Venlafaxine—CYP2C9—blood—hematologic cancer	0.000357	0.0157	CbGeAlD
Venlafaxine—ABCG2—lung—hematologic cancer	0.000343	0.0151	CbGeAlD
Venlafaxine—ABCG2—testis—hematologic cancer	0.000323	0.0143	CbGeAlD
Venlafaxine—CYP2B6—lung—hematologic cancer	0.000316	0.0139	CbGeAlD
Venlafaxine—CYP2B6—testis—hematologic cancer	0.000298	0.0132	CbGeAlD
Venlafaxine—SLC6A2—lymph node—hematologic cancer	0.000293	0.0129	CbGeAlD
Venlafaxine—ABCB1—hematopoietic system—hematologic cancer	0.000291	0.0128	CbGeAlD
Venlafaxine—CYP3A4—blood—hematologic cancer	0.000272	0.012	CbGeAlD
Venlafaxine—CYP2D6—blood—hematologic cancer	0.000268	0.0118	CbGeAlD
Venlafaxine—ABCG2—lymph node—hematologic cancer	0.000234	0.0103	CbGeAlD
Venlafaxine—CYP2D6—testis—hematologic cancer	0.000222	0.00977	CbGeAlD
Venlafaxine—ABCB1—gonad—hematologic cancer	0.000221	0.00975	CbGeAlD
Venlafaxine—ABCB1—blood—hematologic cancer	0.000193	0.0085	CbGeAlD
Venlafaxine—ABCB1—bone marrow—hematologic cancer	0.000187	0.00822	CbGeAlD
Venlafaxine—ABCB1—lung—hematologic cancer	0.000169	0.00745	CbGeAlD
Venlafaxine—ABCB1—testis—hematologic cancer	0.000159	0.00703	CbGeAlD
Venlafaxine—ABCB1—lymph node—hematologic cancer	0.000116	0.0051	CbGeAlD
Venlafaxine—Nausea—Gemcitabine—hematologic cancer	8.01e-06	3.67e-05	CcSEcCtD
Venlafaxine—Vomiting—Cisplatin—hematologic cancer	8e-06	3.66e-05	CcSEcCtD
Venlafaxine—Hyperhidrosis—Prednisone—hematologic cancer	7.98e-06	3.66e-05	CcSEcCtD
Venlafaxine—Vision blurred—Methotrexate—hematologic cancer	7.97e-06	3.65e-05	CcSEcCtD
Venlafaxine—Erythema multiforme—Doxorubicin—hematologic cancer	7.95e-06	3.64e-05	CcSEcCtD
Venlafaxine—Rash—Cisplatin—hematologic cancer	7.93e-06	3.63e-05	CcSEcCtD
Venlafaxine—Dermatitis—Cisplatin—hematologic cancer	7.92e-06	3.63e-05	CcSEcCtD
Venlafaxine—Erythema—Epirubicin—hematologic cancer	7.91e-06	3.63e-05	CcSEcCtD
Venlafaxine—Diarrhoea—Etoposide—hematologic cancer	7.88e-06	3.61e-05	CcSEcCtD
Venlafaxine—Anorexia—Prednisone—hematologic cancer	7.87e-06	3.61e-05	CcSEcCtD
Venlafaxine—Ill-defined disorder—Methotrexate—hematologic cancer	7.85e-06	3.6e-05	CcSEcCtD
Venlafaxine—Tinnitus—Doxorubicin—hematologic cancer	7.84e-06	3.59e-05	CcSEcCtD
Venlafaxine—Anaemia—Methotrexate—hematologic cancer	7.82e-06	3.58e-05	CcSEcCtD
Venlafaxine—Feeling abnormal—Betamethasone—hematologic cancer	7.81e-06	3.58e-05	CcSEcCtD
Venlafaxine—Feeling abnormal—Dexamethasone—hematologic cancer	7.81e-06	3.58e-05	CcSEcCtD
Venlafaxine—Cardiac disorder—Doxorubicin—hematologic cancer	7.81e-06	3.58e-05	CcSEcCtD
Venlafaxine—Flushing—Doxorubicin—hematologic cancer	7.81e-06	3.58e-05	CcSEcCtD
Venlafaxine—Flatulence—Epirubicin—hematologic cancer	7.8e-06	3.57e-05	CcSEcCtD
Venlafaxine—Tension—Epirubicin—hematologic cancer	7.77e-06	3.56e-05	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.75e-06	3.55e-05	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Betamethasone—hematologic cancer	7.75e-06	3.55e-05	CcSEcCtD
Venlafaxine—Dysgeusia—Epirubicin—hematologic cancer	7.75e-06	3.55e-05	CcSEcCtD
Venlafaxine—Hypersensitivity—Triamcinolone—hematologic cancer	7.7e-06	3.53e-05	CcSEcCtD
Venlafaxine—Nervousness—Epirubicin—hematologic cancer	7.69e-06	3.52e-05	CcSEcCtD
Venlafaxine—Back pain—Epirubicin—hematologic cancer	7.65e-06	3.51e-05	CcSEcCtD
Venlafaxine—Malaise—Methotrexate—hematologic cancer	7.63e-06	3.49e-05	CcSEcCtD
Venlafaxine—Dizziness—Etoposide—hematologic cancer	7.62e-06	3.49e-05	CcSEcCtD
Venlafaxine—Muscle spasms—Epirubicin—hematologic cancer	7.61e-06	3.49e-05	CcSEcCtD
Venlafaxine—Vertigo—Methotrexate—hematologic cancer	7.6e-06	3.48e-05	CcSEcCtD
Venlafaxine—Leukopenia—Methotrexate—hematologic cancer	7.57e-06	3.47e-05	CcSEcCtD
Venlafaxine—Chills—Doxorubicin—hematologic cancer	7.55e-06	3.46e-05	CcSEcCtD
Venlafaxine—Urticaria—Dexamethasone—hematologic cancer	7.53e-06	3.45e-05	CcSEcCtD
Venlafaxine—Urticaria—Betamethasone—hematologic cancer	7.53e-06	3.45e-05	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Prednisone—hematologic cancer	7.52e-06	3.45e-05	CcSEcCtD
Venlafaxine—Dizziness—Prednisolone—hematologic cancer	7.51e-06	3.44e-05	CcSEcCtD
Venlafaxine—Arrhythmia—Doxorubicin—hematologic cancer	7.51e-06	3.44e-05	CcSEcCtD
Venlafaxine—Asthenia—Triamcinolone—hematologic cancer	7.5e-06	3.44e-05	CcSEcCtD
Venlafaxine—Body temperature increased—Dexamethasone—hematologic cancer	7.5e-06	3.43e-05	CcSEcCtD
Venlafaxine—Body temperature increased—Betamethasone—hematologic cancer	7.5e-06	3.43e-05	CcSEcCtD
Venlafaxine—Abdominal pain—Dexamethasone—hematologic cancer	7.5e-06	3.43e-05	CcSEcCtD
Venlafaxine—Abdominal pain—Betamethasone—hematologic cancer	7.5e-06	3.43e-05	CcSEcCtD
Venlafaxine—Nausea—Cisplatin—hematologic cancer	7.47e-06	3.42e-05	CcSEcCtD
Venlafaxine—Insomnia—Prednisone—hematologic cancer	7.47e-06	3.42e-05	CcSEcCtD
Venlafaxine—Vision blurred—Epirubicin—hematologic cancer	7.46e-06	3.42e-05	CcSEcCtD
Venlafaxine—Alopecia—Doxorubicin—hematologic cancer	7.43e-06	3.41e-05	CcSEcCtD
Venlafaxine—Paraesthesia—Prednisone—hematologic cancer	7.41e-06	3.4e-05	CcSEcCtD
Venlafaxine—Pruritus—Triamcinolone—hematologic cancer	7.39e-06	3.39e-05	CcSEcCtD
Venlafaxine—Cough—Methotrexate—hematologic cancer	7.38e-06	3.38e-05	CcSEcCtD
Venlafaxine—Ill-defined disorder—Epirubicin—hematologic cancer	7.34e-06	3.36e-05	CcSEcCtD
Venlafaxine—Convulsion—Methotrexate—hematologic cancer	7.33e-06	3.36e-05	CcSEcCtD
Venlafaxine—Vomiting—Etoposide—hematologic cancer	7.33e-06	3.36e-05	CcSEcCtD
Venlafaxine—Erythema—Doxorubicin—hematologic cancer	7.32e-06	3.36e-05	CcSEcCtD
Venlafaxine—Anaemia—Epirubicin—hematologic cancer	7.31e-06	3.35e-05	CcSEcCtD
Venlafaxine—Agitation—Epirubicin—hematologic cancer	7.27e-06	3.33e-05	CcSEcCtD
Venlafaxine—Dyspepsia—Prednisone—hematologic cancer	7.27e-06	3.33e-05	CcSEcCtD
Venlafaxine—Rash—Etoposide—hematologic cancer	7.26e-06	3.33e-05	CcSEcCtD
Venlafaxine—Dermatitis—Etoposide—hematologic cancer	7.26e-06	3.33e-05	CcSEcCtD
Venlafaxine—Headache—Etoposide—hematologic cancer	7.22e-06	3.31e-05	CcSEcCtD
Venlafaxine—Flatulence—Doxorubicin—hematologic cancer	7.21e-06	3.31e-05	CcSEcCtD
Venlafaxine—Chest pain—Methotrexate—hematologic cancer	7.2e-06	3.3e-05	CcSEcCtD
Venlafaxine—Myalgia—Methotrexate—hematologic cancer	7.2e-06	3.3e-05	CcSEcCtD
Venlafaxine—Arthralgia—Methotrexate—hematologic cancer	7.2e-06	3.3e-05	CcSEcCtD
Venlafaxine—Tension—Doxorubicin—hematologic cancer	7.18e-06	3.29e-05	CcSEcCtD
Venlafaxine—Decreased appetite—Prednisone—hematologic cancer	7.18e-06	3.29e-05	CcSEcCtD
Venlafaxine—Dysgeusia—Doxorubicin—hematologic cancer	7.17e-06	3.29e-05	CcSEcCtD
Venlafaxine—Rash—Prednisolone—hematologic cancer	7.16e-06	3.28e-05	CcSEcCtD
Venlafaxine—Dermatitis—Prednisolone—hematologic cancer	7.16e-06	3.28e-05	CcSEcCtD
Venlafaxine—Malaise—Epirubicin—hematologic cancer	7.14e-06	3.27e-05	CcSEcCtD
Venlafaxine—Fatigue—Prednisone—hematologic cancer	7.12e-06	3.26e-05	CcSEcCtD
Venlafaxine—Headache—Prednisolone—hematologic cancer	7.12e-06	3.26e-05	CcSEcCtD
Venlafaxine—Discomfort—Methotrexate—hematologic cancer	7.11e-06	3.26e-05	CcSEcCtD
Venlafaxine—Nervousness—Doxorubicin—hematologic cancer	7.11e-06	3.26e-05	CcSEcCtD
Venlafaxine—Vertigo—Epirubicin—hematologic cancer	7.11e-06	3.26e-05	CcSEcCtD
Venlafaxine—Syncope—Epirubicin—hematologic cancer	7.1e-06	3.25e-05	CcSEcCtD
Venlafaxine—Leukopenia—Epirubicin—hematologic cancer	7.08e-06	3.25e-05	CcSEcCtD
Venlafaxine—Back pain—Doxorubicin—hematologic cancer	7.08e-06	3.25e-05	CcSEcCtD
Venlafaxine—Constipation—Prednisone—hematologic cancer	7.06e-06	3.24e-05	CcSEcCtD
Venlafaxine—Muscle spasms—Doxorubicin—hematologic cancer	7.04e-06	3.23e-05	CcSEcCtD
Venlafaxine—Palpitations—Epirubicin—hematologic cancer	6.99e-06	3.2e-05	CcSEcCtD
Venlafaxine—Confusional state—Methotrexate—hematologic cancer	6.96e-06	3.19e-05	CcSEcCtD
Venlafaxine—Loss of consciousness—Epirubicin—hematologic cancer	6.95e-06	3.19e-05	CcSEcCtD
Venlafaxine—Dizziness—Triamcinolone—hematologic cancer	6.91e-06	3.17e-05	CcSEcCtD
Venlafaxine—Cough—Epirubicin—hematologic cancer	6.91e-06	3.16e-05	CcSEcCtD
Venlafaxine—Anaphylactic shock—Methotrexate—hematologic cancer	6.9e-06	3.16e-05	CcSEcCtD
Venlafaxine—Vision blurred—Doxorubicin—hematologic cancer	6.9e-06	3.16e-05	CcSEcCtD
Venlafaxine—Convulsion—Epirubicin—hematologic cancer	6.86e-06	3.14e-05	CcSEcCtD
Venlafaxine—Infection—Methotrexate—hematologic cancer	6.86e-06	3.14e-05	CcSEcCtD
Venlafaxine—Nausea—Etoposide—hematologic cancer	6.84e-06	3.14e-05	CcSEcCtD
Venlafaxine—Hypertension—Epirubicin—hematologic cancer	6.83e-06	3.13e-05	CcSEcCtD
Venlafaxine—Feeling abnormal—Prednisone—hematologic cancer	6.8e-06	3.12e-05	CcSEcCtD
Venlafaxine—Asthenia—Dexamethasone—hematologic cancer	6.8e-06	3.12e-05	CcSEcCtD
Venlafaxine—Asthenia—Betamethasone—hematologic cancer	6.8e-06	3.12e-05	CcSEcCtD
Venlafaxine—Ill-defined disorder—Doxorubicin—hematologic cancer	6.79e-06	3.11e-05	CcSEcCtD
Venlafaxine—Anaemia—Doxorubicin—hematologic cancer	6.77e-06	3.1e-05	CcSEcCtD
Venlafaxine—Thrombocytopenia—Methotrexate—hematologic cancer	6.76e-06	3.1e-05	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Prednisone—hematologic cancer	6.75e-06	3.09e-05	CcSEcCtD
Venlafaxine—Nausea—Prednisolone—hematologic cancer	6.75e-06	3.09e-05	CcSEcCtD
Venlafaxine—Arthralgia—Epirubicin—hematologic cancer	6.74e-06	3.09e-05	CcSEcCtD
Venlafaxine—Chest pain—Epirubicin—hematologic cancer	6.74e-06	3.09e-05	CcSEcCtD
Venlafaxine—Myalgia—Epirubicin—hematologic cancer	6.74e-06	3.09e-05	CcSEcCtD
Venlafaxine—Agitation—Doxorubicin—hematologic cancer	6.73e-06	3.08e-05	CcSEcCtD
Venlafaxine—Anxiety—Epirubicin—hematologic cancer	6.71e-06	3.08e-05	CcSEcCtD
Venlafaxine—Pruritus—Betamethasone—hematologic cancer	6.71e-06	3.07e-05	CcSEcCtD
Venlafaxine—Pruritus—Dexamethasone—hematologic cancer	6.71e-06	3.07e-05	CcSEcCtD
Venlafaxine—Hyperhidrosis—Methotrexate—hematologic cancer	6.67e-06	3.06e-05	CcSEcCtD
Venlafaxine—Discomfort—Epirubicin—hematologic cancer	6.66e-06	3.05e-05	CcSEcCtD
Venlafaxine—Vomiting—Triamcinolone—hematologic cancer	6.64e-06	3.04e-05	CcSEcCtD
Venlafaxine—Malaise—Doxorubicin—hematologic cancer	6.6e-06	3.03e-05	CcSEcCtD
Venlafaxine—Rash—Triamcinolone—hematologic cancer	6.59e-06	3.02e-05	CcSEcCtD
Venlafaxine—Dry mouth—Epirubicin—hematologic cancer	6.59e-06	3.02e-05	CcSEcCtD
Venlafaxine—Dermatitis—Triamcinolone—hematologic cancer	6.58e-06	3.02e-05	CcSEcCtD
Venlafaxine—Vertigo—Doxorubicin—hematologic cancer	6.58e-06	3.01e-05	CcSEcCtD
Venlafaxine—Anorexia—Methotrexate—hematologic cancer	6.58e-06	3.01e-05	CcSEcCtD
Venlafaxine—Syncope—Doxorubicin—hematologic cancer	6.57e-06	3.01e-05	CcSEcCtD
Venlafaxine—Urticaria—Prednisone—hematologic cancer	6.56e-06	3.01e-05	CcSEcCtD
Venlafaxine—Leukopenia—Doxorubicin—hematologic cancer	6.55e-06	3e-05	CcSEcCtD
Venlafaxine—Headache—Triamcinolone—hematologic cancer	6.55e-06	3e-05	CcSEcCtD
Venlafaxine—Abdominal pain—Prednisone—hematologic cancer	6.53e-06	2.99e-05	CcSEcCtD
Venlafaxine—Body temperature increased—Prednisone—hematologic cancer	6.53e-06	2.99e-05	CcSEcCtD
Venlafaxine—Confusional state—Epirubicin—hematologic cancer	6.51e-06	2.98e-05	CcSEcCtD
Venlafaxine—Diarrhoea—Betamethasone—hematologic cancer	6.49e-06	2.97e-05	CcSEcCtD
Venlafaxine—Diarrhoea—Dexamethasone—hematologic cancer	6.49e-06	2.97e-05	CcSEcCtD
Venlafaxine—Palpitations—Doxorubicin—hematologic cancer	6.47e-06	2.97e-05	CcSEcCtD
Venlafaxine—Anaphylactic shock—Epirubicin—hematologic cancer	6.46e-06	2.96e-05	CcSEcCtD
Venlafaxine—Oedema—Epirubicin—hematologic cancer	6.46e-06	2.96e-05	CcSEcCtD
Venlafaxine—Hypotension—Methotrexate—hematologic cancer	6.45e-06	2.96e-05	CcSEcCtD
Venlafaxine—Loss of consciousness—Doxorubicin—hematologic cancer	6.44e-06	2.95e-05	CcSEcCtD
Venlafaxine—Infection—Epirubicin—hematologic cancer	6.42e-06	2.94e-05	CcSEcCtD
Venlafaxine—Cough—Doxorubicin—hematologic cancer	6.39e-06	2.93e-05	CcSEcCtD
Venlafaxine—Shock—Epirubicin—hematologic cancer	6.35e-06	2.91e-05	CcSEcCtD
Venlafaxine—Convulsion—Doxorubicin—hematologic cancer	6.34e-06	2.91e-05	CcSEcCtD
Venlafaxine—Thrombocytopenia—Epirubicin—hematologic cancer	6.32e-06	2.9e-05	CcSEcCtD
Venlafaxine—Hypertension—Doxorubicin—hematologic cancer	6.32e-06	2.9e-05	CcSEcCtD
Venlafaxine—Tachycardia—Epirubicin—hematologic cancer	6.3e-06	2.89e-05	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	6.29e-06	2.88e-05	CcSEcCtD
Venlafaxine—Dizziness—Dexamethasone—hematologic cancer	6.27e-06	2.87e-05	CcSEcCtD
Venlafaxine—Dizziness—Betamethasone—hematologic cancer	6.27e-06	2.87e-05	CcSEcCtD
Venlafaxine—Hyperhidrosis—Epirubicin—hematologic cancer	6.24e-06	2.86e-05	CcSEcCtD
Venlafaxine—Insomnia—Methotrexate—hematologic cancer	6.24e-06	2.86e-05	CcSEcCtD
Venlafaxine—Myalgia—Doxorubicin—hematologic cancer	6.23e-06	2.86e-05	CcSEcCtD
Venlafaxine—Chest pain—Doxorubicin—hematologic cancer	6.23e-06	2.86e-05	CcSEcCtD
Venlafaxine—Arthralgia—Doxorubicin—hematologic cancer	6.23e-06	2.86e-05	CcSEcCtD
Venlafaxine—Anxiety—Doxorubicin—hematologic cancer	6.21e-06	2.85e-05	CcSEcCtD
Venlafaxine—Nausea—Triamcinolone—hematologic cancer	6.21e-06	2.84e-05	CcSEcCtD
Venlafaxine—Paraesthesia—Methotrexate—hematologic cancer	6.2e-06	2.84e-05	CcSEcCtD
Venlafaxine—Discomfort—Doxorubicin—hematologic cancer	6.16e-06	2.82e-05	CcSEcCtD
Venlafaxine—Anorexia—Epirubicin—hematologic cancer	6.16e-06	2.82e-05	CcSEcCtD
Venlafaxine—Dyspnoea—Methotrexate—hematologic cancer	6.15e-06	2.82e-05	CcSEcCtD
Venlafaxine—Somnolence—Methotrexate—hematologic cancer	6.13e-06	2.81e-05	CcSEcCtD
Venlafaxine—Dry mouth—Doxorubicin—hematologic cancer	6.1e-06	2.79e-05	CcSEcCtD
Venlafaxine—Hypersensitivity—Prednisone—hematologic cancer	6.08e-06	2.79e-05	CcSEcCtD
Venlafaxine—Dyspepsia—Methotrexate—hematologic cancer	6.07e-06	2.78e-05	CcSEcCtD
Venlafaxine—Hypotension—Epirubicin—hematologic cancer	6.03e-06	2.77e-05	CcSEcCtD
Venlafaxine—Vomiting—Dexamethasone—hematologic cancer	6.03e-06	2.76e-05	CcSEcCtD
Venlafaxine—Vomiting—Betamethasone—hematologic cancer	6.03e-06	2.76e-05	CcSEcCtD
Venlafaxine—Confusional state—Doxorubicin—hematologic cancer	6.03e-06	2.76e-05	CcSEcCtD
Venlafaxine—Decreased appetite—Methotrexate—hematologic cancer	6e-06	2.75e-05	CcSEcCtD
Venlafaxine—Rash—Betamethasone—hematologic cancer	5.98e-06	2.74e-05	CcSEcCtD
Venlafaxine—Rash—Dexamethasone—hematologic cancer	5.98e-06	2.74e-05	CcSEcCtD
Venlafaxine—Oedema—Doxorubicin—hematologic cancer	5.98e-06	2.74e-05	CcSEcCtD
Venlafaxine—Anaphylactic shock—Doxorubicin—hematologic cancer	5.98e-06	2.74e-05	CcSEcCtD
Venlafaxine—Dermatitis—Dexamethasone—hematologic cancer	5.97e-06	2.74e-05	CcSEcCtD
Venlafaxine—Dermatitis—Betamethasone—hematologic cancer	5.97e-06	2.74e-05	CcSEcCtD
Venlafaxine—Fatigue—Methotrexate—hematologic cancer	5.95e-06	2.73e-05	CcSEcCtD
Venlafaxine—Headache—Betamethasone—hematologic cancer	5.94e-06	2.72e-05	CcSEcCtD
Venlafaxine—Headache—Dexamethasone—hematologic cancer	5.94e-06	2.72e-05	CcSEcCtD
Venlafaxine—Infection—Doxorubicin—hematologic cancer	5.94e-06	2.72e-05	CcSEcCtD
Venlafaxine—Asthenia—Prednisone—hematologic cancer	5.92e-06	2.71e-05	CcSEcCtD
Venlafaxine—Pain—Methotrexate—hematologic cancer	5.9e-06	2.7e-05	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.88e-06	2.7e-05	CcSEcCtD
Venlafaxine—Shock—Doxorubicin—hematologic cancer	5.88e-06	2.69e-05	CcSEcCtD
Venlafaxine—Thrombocytopenia—Doxorubicin—hematologic cancer	5.85e-06	2.68e-05	CcSEcCtD
Venlafaxine—Pruritus—Prednisone—hematologic cancer	5.84e-06	2.68e-05	CcSEcCtD
Venlafaxine—Insomnia—Epirubicin—hematologic cancer	5.84e-06	2.68e-05	CcSEcCtD
Venlafaxine—Tachycardia—Doxorubicin—hematologic cancer	5.83e-06	2.67e-05	CcSEcCtD
Venlafaxine—Paraesthesia—Epirubicin—hematologic cancer	5.8e-06	2.66e-05	CcSEcCtD
Venlafaxine—Hyperhidrosis—Doxorubicin—hematologic cancer	5.78e-06	2.65e-05	CcSEcCtD
Venlafaxine—Dyspnoea—Epirubicin—hematologic cancer	5.76e-06	2.64e-05	CcSEcCtD
Venlafaxine—Somnolence—Epirubicin—hematologic cancer	5.74e-06	2.63e-05	CcSEcCtD
Venlafaxine—Anorexia—Doxorubicin—hematologic cancer	5.7e-06	2.61e-05	CcSEcCtD
Venlafaxine—Feeling abnormal—Methotrexate—hematologic cancer	5.69e-06	2.61e-05	CcSEcCtD
Venlafaxine—Dyspepsia—Epirubicin—hematologic cancer	5.68e-06	2.61e-05	CcSEcCtD
Venlafaxine—Diarrhoea—Prednisone—hematologic cancer	5.65e-06	2.59e-05	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Methotrexate—hematologic cancer	5.64e-06	2.59e-05	CcSEcCtD
Venlafaxine—Nausea—Dexamethasone—hematologic cancer	5.63e-06	2.58e-05	CcSEcCtD
Venlafaxine—Nausea—Betamethasone—hematologic cancer	5.63e-06	2.58e-05	CcSEcCtD
Venlafaxine—Decreased appetite—Epirubicin—hematologic cancer	5.61e-06	2.57e-05	CcSEcCtD
Venlafaxine—Hypotension—Doxorubicin—hematologic cancer	5.58e-06	2.56e-05	CcSEcCtD
Venlafaxine—Fatigue—Epirubicin—hematologic cancer	5.57e-06	2.55e-05	CcSEcCtD
Venlafaxine—Pain—Epirubicin—hematologic cancer	5.52e-06	2.53e-05	CcSEcCtD
Venlafaxine—Constipation—Epirubicin—hematologic cancer	5.52e-06	2.53e-05	CcSEcCtD
Venlafaxine—Urticaria—Methotrexate—hematologic cancer	5.48e-06	2.51e-05	CcSEcCtD
Venlafaxine—Dizziness—Prednisone—hematologic cancer	5.46e-06	2.5e-05	CcSEcCtD
Venlafaxine—Abdominal pain—Methotrexate—hematologic cancer	5.46e-06	2.5e-05	CcSEcCtD
Venlafaxine—Body temperature increased—Methotrexate—hematologic cancer	5.46e-06	2.5e-05	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.44e-06	2.49e-05	CcSEcCtD
Venlafaxine—Insomnia—Doxorubicin—hematologic cancer	5.4e-06	2.48e-05	CcSEcCtD
Venlafaxine—Paraesthesia—Doxorubicin—hematologic cancer	5.37e-06	2.46e-05	CcSEcCtD
Venlafaxine—Dyspnoea—Doxorubicin—hematologic cancer	5.33e-06	2.44e-05	CcSEcCtD
Venlafaxine—Feeling abnormal—Epirubicin—hematologic cancer	5.32e-06	2.44e-05	CcSEcCtD
Venlafaxine—Somnolence—Doxorubicin—hematologic cancer	5.31e-06	2.43e-05	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Epirubicin—hematologic cancer	5.28e-06	2.42e-05	CcSEcCtD
Venlafaxine—Dyspepsia—Doxorubicin—hematologic cancer	5.26e-06	2.41e-05	CcSEcCtD
Venlafaxine—Vomiting—Prednisone—hematologic cancer	5.25e-06	2.41e-05	CcSEcCtD
Venlafaxine—Rash—Prednisone—hematologic cancer	5.21e-06	2.39e-05	CcSEcCtD
Venlafaxine—Dermatitis—Prednisone—hematologic cancer	5.2e-06	2.38e-05	CcSEcCtD
Venlafaxine—Decreased appetite—Doxorubicin—hematologic cancer	5.19e-06	2.38e-05	CcSEcCtD
Venlafaxine—Headache—Prednisone—hematologic cancer	5.17e-06	2.37e-05	CcSEcCtD
Venlafaxine—Fatigue—Doxorubicin—hematologic cancer	5.15e-06	2.36e-05	CcSEcCtD
Venlafaxine—Urticaria—Epirubicin—hematologic cancer	5.13e-06	2.35e-05	CcSEcCtD
Venlafaxine—Pain—Doxorubicin—hematologic cancer	5.11e-06	2.34e-05	CcSEcCtD
Venlafaxine—Constipation—Doxorubicin—hematologic cancer	5.11e-06	2.34e-05	CcSEcCtD
Venlafaxine—Abdominal pain—Epirubicin—hematologic cancer	5.11e-06	2.34e-05	CcSEcCtD
Venlafaxine—Body temperature increased—Epirubicin—hematologic cancer	5.11e-06	2.34e-05	CcSEcCtD
Venlafaxine—Hypersensitivity—Methotrexate—hematologic cancer	5.08e-06	2.33e-05	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—GSTP1—hematologic cancer	5e-06	9.25e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NCOR2—hematologic cancer	4.99e-06	9.23e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PC—hematologic cancer	4.98e-06	9.21e-05	CbGpPWpGaD
Venlafaxine—Asthenia—Methotrexate—hematologic cancer	4.95e-06	2.27e-05	CcSEcCtD
Venlafaxine—Feeling abnormal—Doxorubicin—hematologic cancer	4.92e-06	2.26e-05	CcSEcCtD
Venlafaxine—ABCB1—Metabolism—SPHK1—hematologic cancer	4.92e-06	9.1e-05	CbGpPWpGaD
Venlafaxine—Nausea—Prednisone—hematologic cancer	4.9e-06	2.25e-05	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.89e-06	2.24e-05	CcSEcCtD
Venlafaxine—Pruritus—Methotrexate—hematologic cancer	4.88e-06	2.24e-05	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CA—hematologic cancer	4.86e-06	8.98e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—UGT1A1—hematologic cancer	4.85e-06	8.96e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GBA—hematologic cancer	4.81e-06	8.89e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	4.81e-06	8.89e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—IDH1—hematologic cancer	4.79e-06	8.86e-05	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Epirubicin—hematologic cancer	4.76e-06	2.18e-05	CcSEcCtD
Venlafaxine—CYP2C9—Metabolism—IDH1—hematologic cancer	4.75e-06	8.79e-05	CbGpPWpGaD
Venlafaxine—Urticaria—Doxorubicin—hematologic cancer	4.75e-06	2.18e-05	CcSEcCtD
Venlafaxine—CYP2D6—Metabolism—TXN—hematologic cancer	4.74e-06	8.77e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ABCC3—hematologic cancer	4.74e-06	8.77e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTO1—hematologic cancer	4.74e-06	8.77e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ABCB1—hematologic cancer	4.73e-06	8.75e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—UGT1A1—hematologic cancer	4.73e-06	8.75e-05	CbGpPWpGaD
Venlafaxine—Body temperature increased—Doxorubicin—hematologic cancer	4.72e-06	2.16e-05	CcSEcCtD
Venlafaxine—Abdominal pain—Doxorubicin—hematologic cancer	4.72e-06	2.16e-05	CcSEcCtD
Venlafaxine—Diarrhoea—Methotrexate—hematologic cancer	4.72e-06	2.16e-05	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism—CRABP1—hematologic cancer	4.71e-06	8.72e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SLC22A1—hematologic cancer	4.71e-06	8.72e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ABCC3—hematologic cancer	4.7e-06	8.69e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TXN—hematologic cancer	4.7e-06	8.69e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTO1—hematologic cancer	4.7e-06	8.69e-05	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TP53—hematologic cancer	4.7e-06	8.69e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SPHK1—hematologic cancer	4.64e-06	8.58e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.63e-06	8.57e-05	CbGpPWpGaD
Venlafaxine—Asthenia—Epirubicin—hematologic cancer	4.63e-06	2.12e-05	CcSEcCtD
Venlafaxine—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.6e-06	8.51e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CRABP1—hematologic cancer	4.6e-06	8.51e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SPHK1—hematologic cancer	4.6e-06	8.5e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTM1—hematologic cancer	4.6e-06	8.5e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—NCOR1—hematologic cancer	4.6e-06	8.5e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ALOX5—hematologic cancer	4.59e-06	8.49e-05	CbGpPWpGaD
Venlafaxine—Pruritus—Epirubicin—hematologic cancer	4.57e-06	2.09e-05	CcSEcCtD
Venlafaxine—Dizziness—Methotrexate—hematologic cancer	4.56e-06	2.09e-05	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—HRAS—hematologic cancer	4.49e-06	8.31e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ALOX5—hematologic cancer	4.48e-06	8.29e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.48e-06	8.29e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	4.46e-06	8.24e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NUP98—hematologic cancer	4.45e-06	8.23e-05	CbGpPWpGaD
Venlafaxine—Diarrhoea—Epirubicin—hematologic cancer	4.42e-06	2.02e-05	CcSEcCtD
Venlafaxine—CYP2C9—Metabolism—UGT1A1—hematologic cancer	4.42e-06	8.17e-05	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Doxorubicin—hematologic cancer	4.4e-06	2.02e-05	CcSEcCtD
Venlafaxine—CYP3A4—Metabolism—MTAP—hematologic cancer	4.4e-06	8.13e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CD44—hematologic cancer	4.4e-06	8.13e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NQO1—hematologic cancer	4.4e-06	8.13e-05	CbGpPWpGaD
Venlafaxine—Vomiting—Methotrexate—hematologic cancer	4.39e-06	2.01e-05	CcSEcCtD
Venlafaxine—Rash—Methotrexate—hematologic cancer	4.35e-06	1.99e-05	CcSEcCtD
Venlafaxine—Dermatitis—Methotrexate—hematologic cancer	4.35e-06	1.99e-05	CcSEcCtD
Venlafaxine—ABCB1—Metabolism—NUP98—hematologic cancer	4.34e-06	8.03e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	4.34e-06	8.02e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CRABP1—hematologic cancer	4.34e-06	8.02e-05	CbGpPWpGaD
Venlafaxine—Headache—Methotrexate—hematologic cancer	4.32e-06	1.98e-05	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism—ADCY7—hematologic cancer	4.32e-06	7.99e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NCOA3—hematologic cancer	4.32e-06	7.99e-05	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL6—hematologic cancer	4.3e-06	7.95e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CRABP1—hematologic cancer	4.3e-06	7.95e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SLC22A1—hematologic cancer	4.3e-06	7.95e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NUP214—hematologic cancer	4.29e-06	7.93e-05	CbGpPWpGaD
Venlafaxine—Asthenia—Doxorubicin—hematologic cancer	4.29e-06	1.96e-05	CcSEcCtD
Venlafaxine—Dizziness—Epirubicin—hematologic cancer	4.27e-06	1.96e-05	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.24e-06	7.85e-05	CbGpPWpGaD
Venlafaxine—Pruritus—Doxorubicin—hematologic cancer	4.23e-06	1.94e-05	CcSEcCtD
Venlafaxine—CYP2D6—Metabolism—ALOX5—hematologic cancer	4.23e-06	7.81e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ADCY7—hematologic cancer	4.22e-06	7.79e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NCOA3—hematologic cancer	4.22e-06	7.79e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—MTR—hematologic cancer	4.2e-06	7.77e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ABCG2—hematologic cancer	4.2e-06	7.77e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ALOX5—hematologic cancer	4.19e-06	7.74e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NUP214—hematologic cancer	4.19e-06	7.74e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYCS—hematologic cancer	4.16e-06	7.69e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	4.13e-06	7.64e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ENO2—hematologic cancer	4.12e-06	7.62e-05	CbGpPWpGaD
Venlafaxine—Vomiting—Epirubicin—hematologic cancer	4.11e-06	1.88e-05	CcSEcCtD
Venlafaxine—ABCB1—Metabolism—ABCG2—hematologic cancer	4.1e-06	7.58e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—MTR—hematologic cancer	4.1e-06	7.58e-05	CbGpPWpGaD
Venlafaxine—Nausea—Methotrexate—hematologic cancer	4.1e-06	1.88e-05	CcSEcCtD
Venlafaxine—CYP2D6—Metabolism—NUP98—hematologic cancer	4.09e-06	7.57e-05	CbGpPWpGaD
Venlafaxine—Diarrhoea—Doxorubicin—hematologic cancer	4.09e-06	1.87e-05	CcSEcCtD
Venlafaxine—Rash—Epirubicin—hematologic cancer	4.07e-06	1.87e-05	CcSEcCtD
Venlafaxine—Dermatitis—Epirubicin—hematologic cancer	4.07e-06	1.86e-05	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—MTHFR—hematologic cancer	4.06e-06	7.51e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NUP98—hematologic cancer	4.06e-06	7.5e-05	CbGpPWpGaD
Venlafaxine—Headache—Epirubicin—hematologic cancer	4.05e-06	1.85e-05	CcSEcCtD
Venlafaxine—ABCB1—Metabolism—ENO2—hematologic cancer	4.02e-06	7.44e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTT1—hematologic cancer	4e-06	7.39e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ADCY7—hematologic cancer	3.97e-06	7.35e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NCOA3—hematologic cancer	3.97e-06	7.35e-05	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—AKT1—hematologic cancer	3.97e-06	7.33e-05	CbGpPWpGaD
Venlafaxine—Dizziness—Doxorubicin—hematologic cancer	3.95e-06	1.81e-05	CcSEcCtD
Venlafaxine—CYP2D6—Metabolism—NUP214—hematologic cancer	3.94e-06	7.29e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ADCY7—hematologic cancer	3.94e-06	7.28e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NCOA3—hematologic cancer	3.94e-06	7.28e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.93e-06	7.28e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—FHL2—hematologic cancer	3.92e-06	7.25e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NUP214—hematologic cancer	3.91e-06	7.23e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SDC1—hematologic cancer	3.91e-06	7.22e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTT1—hematologic cancer	3.9e-06	7.21e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.87e-06	7.16e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—MTR—hematologic cancer	3.86e-06	7.15e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ABCG2—hematologic cancer	3.86e-06	7.15e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—AGRN—hematologic cancer	3.84e-06	7.11e-05	CbGpPWpGaD
Venlafaxine—Nausea—Epirubicin—hematologic cancer	3.84e-06	1.76e-05	CcSEcCtD
Venlafaxine—CYP2C9—Metabolism—MTR—hematologic cancer	3.83e-06	7.08e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ABCG2—hematologic cancer	3.83e-06	7.08e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SDC1—hematologic cancer	3.81e-06	7.05e-05	CbGpPWpGaD
Venlafaxine—Vomiting—Doxorubicin—hematologic cancer	3.8e-06	1.74e-05	CcSEcCtD
Venlafaxine—CYP2D6—Metabolism—ENO2—hematologic cancer	3.79e-06	7.01e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.79e-06	7e-05	CbGpPWpGaD
Venlafaxine—Rash—Doxorubicin—hematologic cancer	3.77e-06	1.73e-05	CcSEcCtD
Venlafaxine—Dermatitis—Doxorubicin—hematologic cancer	3.76e-06	1.73e-05	CcSEcCtD
Venlafaxine—CYP2C9—Metabolism—ENO2—hematologic cancer	3.76e-06	6.95e-05	CbGpPWpGaD
Venlafaxine—Headache—Doxorubicin—hematologic cancer	3.74e-06	1.72e-05	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.73e-06	6.9e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.68e-06	6.81e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTT1—hematologic cancer	3.68e-06	6.8e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTP1—hematologic cancer	3.67e-06	6.78e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.65e-06	6.75e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—IDH2—hematologic cancer	3.65e-06	6.74e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—HMMR—hematologic cancer	3.65e-06	6.74e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.64e-06	6.74e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SDC1—hematologic cancer	3.59e-06	6.64e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.59e-06	6.63e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SDC1—hematologic cancer	3.56e-06	6.59e-05	CbGpPWpGaD
Venlafaxine—Nausea—Doxorubicin—hematologic cancer	3.55e-06	1.63e-05	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.52e-06	6.51e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ABCB1—hematologic cancer	3.47e-06	6.42e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.43e-06	6.34e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.42e-06	6.32e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CG—hematologic cancer	3.41e-06	6.31e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.4e-06	6.29e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NCOR1—hematologic cancer	3.37e-06	6.23e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTM1—hematologic cancer	3.37e-06	6.23e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.36e-06	6.21e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CA9—hematologic cancer	3.33e-06	6.16e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ACP5—hematologic cancer	3.33e-06	6.16e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CD44—hematologic cancer	3.32e-06	6.14e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NQO1—hematologic cancer	3.32e-06	6.14e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.29e-06	6.08e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.25e-06	6.01e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NQO1—hematologic cancer	3.24e-06	5.99e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CD44—hematologic cancer	3.24e-06	5.99e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.21e-06	5.94e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CREBBP—hematologic cancer	3.16e-06	5.85e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYCS—hematologic cancer	3.14e-06	5.81e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—IDH1—hematologic cancer	3.13e-06	5.8e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.12e-06	5.77e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.1e-06	5.73e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TXN—hematologic cancer	3.1e-06	5.73e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.1e-06	5.73e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYCS—hematologic cancer	3.07e-06	5.67e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CD44—hematologic cancer	3.05e-06	5.65e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NQO1—hematologic cancer	3.05e-06	5.65e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.05e-06	5.64e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.03e-06	5.61e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CD44—hematologic cancer	3.03e-06	5.6e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NQO1—hematologic cancer	3.03e-06	5.6e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CD—hematologic cancer	3e-06	5.55e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—MTHFR—hematologic cancer	2.98e-06	5.5e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.97e-06	5.48e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ALB—hematologic cancer	2.96e-06	5.48e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.91e-06	5.39e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYCS—hematologic cancer	2.89e-06	5.34e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.87e-06	5.31e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYCS—hematologic cancer	2.87e-06	5.3e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.85e-06	5.26e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.83e-06	5.24e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.83e-06	5.24e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3R1—hematologic cancer	2.83e-06	5.24e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.81e-06	5.2e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.77e-06	5.12e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.76e-06	5.11e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTP1—hematologic cancer	2.7e-06	5e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.68e-06	4.96e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NUP98—hematologic cancer	2.68e-06	4.95e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.62e-06	4.85e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CB—hematologic cancer	2.61e-06	4.83e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.6e-06	4.8e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.6e-06	4.8e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NUP214—hematologic cancer	2.58e-06	4.77e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.56e-06	4.74e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.55e-06	4.71e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.55e-06	4.71e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.55e-06	4.71e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—MTR—hematologic cancer	2.53e-06	4.67e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.53e-06	4.67e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.53e-06	4.67e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.5e-06	4.62e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTM1—hematologic cancer	2.48e-06	4.59e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NCOR1—hematologic cancer	2.48e-06	4.59e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.48e-06	4.58e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.44e-06	4.52e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.41e-06	4.46e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.4e-06	4.44e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.39e-06	4.42e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.35e-06	4.34e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.34e-06	4.33e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.34e-06	4.33e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.32e-06	4.29e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.32e-06	4.29e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.32e-06	4.29e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTEN—hematologic cancer	2.26e-06	4.18e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.25e-06	4.16e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.2e-06	4.07e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—MTHFR—hematologic cancer	2.2e-06	4.06e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ALB—hematologic cancer	2.17e-06	4.01e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—EP300—hematologic cancer	2.15e-06	3.98e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.08e-06	3.84e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.07e-06	3.83e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.05e-06	3.79e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NQO1—hematologic cancer	2e-06	3.69e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CD44—hematologic cancer	2e-06	3.69e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.98e-06	3.67e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	1.92e-06	3.54e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.89e-06	3.49e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYCS—hematologic cancer	1.89e-06	3.49e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.88e-06	3.47e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.84e-06	3.41e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.81e-06	3.34e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.75e-06	3.24e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.74e-06	3.21e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.72e-06	3.19e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.71e-06	3.16e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.67e-06	3.08e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.66e-06	3.07e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTEN—hematologic cancer	1.66e-06	3.06e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ALB—hematologic cancer	1.64e-06	3.03e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.62e-06	3e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.61e-06	2.98e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ALB—hematologic cancer	1.6e-06	2.96e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.6e-06	2.95e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CA—hematologic cancer	1.59e-06	2.95e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—EP300—hematologic cancer	1.58e-06	2.92e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.58e-06	2.92e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.57e-06	2.9e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.53e-06	2.83e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.53e-06	2.83e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.53e-06	2.83e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.53e-06	2.83e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.52e-06	2.8e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ALB—hematologic cancer	1.51e-06	2.79e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ALB—hematologic cancer	1.5e-06	2.77e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.45e-06	2.68e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.44e-06	2.67e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.43e-06	2.65e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.41e-06	2.61e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.35e-06	2.5e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.33e-06	2.46e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.32e-06	2.44e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—AKT1—hematologic cancer	1.3e-06	2.41e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.25e-06	2.31e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTEN—hematologic cancer	1.22e-06	2.26e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—EP300—hematologic cancer	1.19e-06	2.21e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.17e-06	2.16e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—EP300—hematologic cancer	1.16e-06	2.15e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.15e-06	2.13e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.14e-06	2.11e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.14e-06	2.1e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—EP300—hematologic cancer	1.1e-06	2.03e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—EP300—hematologic cancer	1.09e-06	2.01e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.05e-06	1.95e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	9.99e-07	1.85e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ALB—hematologic cancer	9.86e-07	1.82e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—AKT1—hematologic cancer	9.54e-07	1.76e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	9.44e-07	1.74e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	8.83e-07	1.63e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	8.71e-07	1.61e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CA—hematologic cancer	8.62e-07	1.59e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	8.12e-07	1.5e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	8.05e-07	1.49e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTEN—hematologic cancer	7.53e-07	1.39e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—AKT1—hematologic cancer	7.21e-07	1.33e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—EP300—hematologic cancer	7.18e-07	1.33e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—AKT1—hematologic cancer	7.04e-07	1.3e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—AKT1—hematologic cancer	6.63e-07	1.23e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—AKT1—hematologic cancer	6.58e-07	1.22e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.31e-07	9.82e-06	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—AKT1—hematologic cancer	4.34e-07	8.02e-06	CbGpPWpGaD
